The U.S. Lags on Clinical Trial Startup Times
A U.S. pilot can adopt operational features of the Australian and Norwegian models to streamline its trial start-up timeline, without sacrificing scientific, ethical, or safety governance.
Comparison table of first-in-human clinical trial startup requirements across five country or regulatory systems — the United States, Australia CTN, Australia CTA, Norway NorTrials, and China NMPA — where Australia and Norway show significantly faster enrollment pathways than the United States.
